Cutaneous Surgery Outcomes in Patients on Epidermal Growth Factor Receptor Inhibitors

被引：0
|
作者：
Robinson, Michelle A. [1 ]
Patel, Anisha B. [2 ,3 ]
Wilmas, Kelly M. [2 ]
Thomas, Valencia [3 ]
Heberton, Meghan [3 ]
机构：
[1] John P & Katherine G McGovern Med Sch, Houston, TX 77030 USA
[2] John P & Katherine G McGovern Med Sch, Dept Dermatol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA
来源：
DERMATOLOGIC SURGERY | 2021年 / 47卷 / 11期
关键词：
D O I：
10.1097/DSS.0000000000003214
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1519 / 1521
页数：3
相关论文
共 50 条
  • [21] Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients
    Paul, Tanusree
    Schumann, Christian
    Ruediger, Stefan
    Boeck, Stefan
    Heinemann, Volker
    Kaechele, Volker
    Steffens, Michael
    Scholl, Catharina
    Hichert, Vivien
    Seufferlein, Thomas
    Stingl, Julia Carolin
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (11) : 1855 - 1863
  • [22] Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors
    Chang, Huang-Chih
    Chen, Yu-Mu
    Tseng, Chia-Cheng
    Huang, Kuo-Tung
    Wang, Chin-Chou
    Chen, Yung-Che
    Lai, Chien-Hao
    Fang, Wen-Feng
    Kao, Hsu-Ching
    Lin, Meng-Chih
    TUMOR BIOLOGY, 2017, 39 (03) : 1 - 7
  • [23] Cutaneous adverse events of epidermal growth factor receptor inhibitors: A retrospective review of 99 cases
    Chanprapaph, Kumutnart
    Pongcharoen, Padcha
    Vachiramon, Vasanop
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2015, 81 (05): : 547
  • [24] Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management
    Hu, Jenny C.
    Sadeghi, Parrish
    Pinter-Brown, Lauren C.
    Yashar, Sharona
    Chin, Melvin W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : 317 - 326
  • [25] Towards the pathogenesis of cutaneous side-effects induced by inhibitors of the epidermal growth factor receptor
    Gerber, P. A.
    Kellermann, S.
    Enderlein, E.
    Ansari, P.
    Kubitza, R.
    Guadarrama-Gonzalez, R.
    Mackenzie, C.
    Homey, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S38 - S38
  • [26] Cutaneous reactions due to the use of epidermal growth factor receptor inhibitors: two case reports
    Rodarte, Camila Martins
    Abdallah, Omar Ali
    Barbosa, Nadyesda Fagundes
    Koch, Ludmila de Oliveira
    Resende, Uira Maira
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2009, 84 (06) : 667 - 670
  • [27] An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors
    Amador, ML
    Oppenheimer, D
    Perea, S
    Maitra, A
    Cusati, G
    Iacobuzio-Donahue, C
    Baker, SD
    Ashfaq, R
    Takimoto, C
    Forastiere, A
    Hidalgo, M
    CANCER RESEARCH, 2004, 64 (24) : 9139 - 9143
  • [28] Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation
    Mok, Tony S. K.
    D'arcangelo, Manolo
    Califano, Raffaele
    DRUGS, 2012, 72 : 3 - 10
  • [29] Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation
    Tony S. K. Mok
    Manolo D’arcangelo
    Raffaele Califano
    Drugs, 2012, 72 : 3 - 10
  • [30] Epidermal Growth Factor and Epidermal Growth Factor Receptor: The Yin and Yang in the Treatment of Cutaneous Wounds and Cancer
    Bodnar, Richard J.
    ADVANCES IN WOUND CARE, 2013, 2 (01) : 24 - 29
12345